Free Trial
Ends Tomorrow! Last Chance to Get MarketBeat All Access at $149
  • 0Days
  • 0Hours
  • 0Minutes
  • 0Seconds
Lock In $149
Claim MarketBeat All Access Sale Promotion

Q3 Earnings Estimate for Innospec Issued By Freedom Capital

Innospec logo with Materials background
Image from MarketBeat Media, LLC.

Key Points

  • Freedom Capital estimates Innospec will report Q3 2026 EPS of $1.25, compared with a consensus full-year EPS estimate of $5.01.
  • Innospec’s latest quarter exceeded expectations, with EPS of $1.27 versus the $1.05 consensus and revenue of $491.4 million versus $457.25 million; revenue rose 11.8% year over year.
  • Shares recently traded near their 12-month high at $100.70, while analysts maintain a consensus “Hold” rating and institutional investors own 96.64% of the stock.
  • Five stocks we like better than Innospec.

Innospec Inc. (NASDAQ:IOSP - Free Report) - Research analysts at Freedom Capital issued their Q3 2026 earnings per share estimates for Innospec in a report issued on Monday, October 26th. Freedom Capital analyst D. Silver anticipates that the specialty chemicals company will post earnings per share of $1.25 for the quarter. The consensus estimate for Innospec's current full-year earnings is $5.01 per share.

Innospec (NASDAQ:IOSP - Get Free Report) last announced its quarterly earnings results on Tuesday, August 4th. The specialty chemicals company reported $1.27 earnings per share for the quarter, topping analysts' consensus estimates of $1.05 by $0.22. The firm had revenue of $491.40 million for the quarter, compared to the consensus estimate of $457.25 million. Innospec had a return on equity of 9.22% and a net margin of 6.60%. The business's revenue was up 11.8% compared to the same quarter last year. During the same quarter in the previous year, the business earned $1.26 earnings per share.

Other equities research analysts also recently issued research reports about the company. Wall Street Zen downgraded Innospec from a "strong-buy" rating to a "buy" rating in a report on Saturday, September 26th. Weiss Ratings raised shares of Innospec from a "hold (c)" rating to a "hold (c+)" rating in a research report on Thursday, October 8th. Finally, Seaport Research Partners reiterated a "buy" rating and issued a $110.00 price objective on shares of Innospec in a report on Thursday, August 6th. Two investment analysts have rated the stock with a Hold rating. According to MarketBeat.com, the stock currently has a consensus rating of "Hold".

Check Out Our Latest Report on IOSP

Innospec Trading Up 0.8%

Shares of NASDAQ IOSP opened at $100.70 on Thursday. Innospec has a 12 month low of $65.51 and a 12 month high of $100.76. The stock has a 50 day moving average of $95.74 and a 200-day moving average of $84.21. The company has a market capitalization of $2.48 billion, a P/E ratio of 20.55, a P/E/G ratio of 2.63 and a beta of 0.90.

Hedge Funds Weigh In On Innospec

A number of large investors have recently made changes to their positions in IOSP. Root Financial Partners LLC acquired a new position in shares of Innospec during the 3rd quarter worth approximately $30,000. Meeder Asset Management Inc. acquired a new stake in shares of Innospec in the second quarter valued at approximately $36,000. State of Wyoming acquired a new stake in shares of Innospec in the third quarter valued at approximately $46,000. Rockefeller Capital Management L.P. raised its position in shares of Innospec by 125.4% in the fourth quarter. Rockefeller Capital Management L.P. now owns 728 shares of the specialty chemicals company's stock valued at $56,000 after buying an additional 405 shares in the last quarter. Finally, Public Employees Retirement System of Ohio bought a new stake in shares of Innospec in the second quarter valued at approximately $62,000. Institutional investors own 96.64% of the company's stock.

About Innospec

(Get Free Report)

Innospec Inc NASDAQ: IOSP is a global specialty chemicals company that develops, manufactures and markets products used in the fuel, oilfield, personal care and industrial markets. The company serves customers through a portfolio of chemical additives, formulations and technical services designed to improve product performance, efficiency and reliability.

Innospec operates through businesses focused on fuel specialties, performance chemicals and oilfield services. Its fuel-related products include fuel additives for gasoline, diesel, marine and other applications, including detergents, lubricity improvers, cetane improvers and other performance-enhancing formulations.

Read More

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Innospec Right Now?

Before you consider Innospec, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Innospec wasn't on the list.

While Innospec currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Forget Nvidia, Meta, and Google. Here's The New Magnificent Seven. Cover

Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2026. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.

Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines